SOLIGENIX, INC. Uncategorized Contracts & Agreements
39 Contracts & Agreements
- Description of Securities (Filed With SEC on March 15, 2024)
- Form of Placement Agent Agreement (Filed With SEC on January 16, 2024)
- Form of Placement Agent Agreement (Filed With SEC on April 20, 2023)
- Description of Securities (Filed With SEC on March 31, 2023)
- Description of Securities (Filed With SEC on March 29, 2022)
- Description of Securities (Filed With SEC on March 30, 2021)
- Certification of Chief Executive Officer pursuant to Exchange Act rule 13(a)-14(a) (under Section 302 of the Sarbanes-Oxley Act of 2002) (Filed With SEC on November 12, 2020)
- Description of Securities (Filed With SEC on March 30, 2020)
- WARRANTAGENCY AGREEMENT (Filed With SEC on December 16, 2016)
- FORMOF UNDERWRITINGAGREEMENT between SOLIGENIX,INC. and AEGISCAPITAL CORP., asRepresentative of the Several Underwriters (Filed With SEC on November 14, 2016)
- EMPLOYMENTAGREEMENT (Filed With SEC on June 22, 2016)
- PURCHASEAGREEMENT (Filed With SEC on March 24, 2016)
- SOLIGENIX,INC. PROMISSORYNOTE DUE April 15, 2016 (Filed With SEC on July 31, 2015)
- EQUITYPURCHASE AGREEMENT (Filed With SEC on July 31, 2015)
- CONTRACT TABLE OF CONTENTS (Filed With SEC on September 23, 2014)
- REDACTED VERSION (Filed With SEC on September 5, 2014)
- Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of 1934, as amended.A... (Filed With SEC on September 30, 2013)
- FORM OF (Filed With SEC on May 8, 2013)
- /s/ Robert J. RubinRobert J. Rubin (Filed With SEC on July 9, 2010)
- /s/ Gregg A. LapointeGregg A. Lapointe (Filed With SEC on July 9, 2010)
- Sigma Tau Pharmaceuticals, Inc. /s/ Gregg A. LapointeGregg A. LapointeChief Executive Officer (Filed With SEC on July 9, 2010)
- [DORBIOPHARMA, INC. LETTERHEAD] (Filed With SEC on October 7, 2009)
- [DORBIOPHARMA, INC. LETTERHEAD] (Filed With SEC on October 7, 2009)
- EMPLOYMENTAGREEMENT (Filed With SEC on July 7, 2009)
- EXHIBITA ExhibitB OFFICEINVENTORY - 29 Emmons Drive, Princeton, NJ (Filed With SEC on April 14, 2009)
- EMPLOYMENTAGREEMENT (Filed With SEC on March 30, 2009)
- EMPLOYMENTAGREEMENT (Filed With SEC on March 30, 2009)
- EMPLOYMENTAGREEMENT (Filed With SEC on March 30, 2009)
- EMPLOYMENTAGREEMENT (Filed With SEC on March 16, 2009)
- EXCLUSIVE LICENSEAGREEMENT (Filed With SEC on February 13, 2009)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on January 21, 2009)
- LETTER OF INTENT (Filed With SEC on December 1, 2008)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on April 1, 2008)
- Form of Right Certificate (Filed With SEC on June 22, 2007)
- Dedicated to providing new therapies and new hope for patients with rare diseases (Filed With SEC on May 4, 2007)
- Exhibit 10.1 (Filed With SEC on February 23, 2007)
- LETTER OF INTENT (Filed With SEC on January 4, 2007)
- DOR BioPharma, Inc. 1691 Michigan Avenue Miami, Florida 33139 www.dorbiopharma.com DOR BioPharma Executes Letter of Intent for Acquisition of Gastrotech Pharma Acquisition... (Filed With SEC on November 2, 2005)
- Exhibit 10.1 (Filed With SEC on November 2, 2005)
